Hansoh Pharmaceutical Group Company Limited (HKG:3692)
34.08
+0.36 (1.07%)
Mar 10, 2026, 10:55 AM HKT
HKG:3692 Revenue
Hansoh Pharmaceutical Group Company had revenue of 7.43B CNY in the half year ending June 30, 2025, with 64.78% growth. This brings the company's revenue in the last twelve months to 13.19B, up 9.02% year-over-year. In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B with 21.35% growth.
Revenue (ttm)
13.19B CNY
Revenue Growth
+9.02%
P/S Ratio
14.13
Revenue / Employee
1.42M CNY
Employees
9,313
Market Cap
204.14B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Medical System Holdings | 8.61B |
| Simcere Pharmaceutical Group | 7.79B |
| China Resources Pharmaceutical Group | 285.94B |
| Grand Pharmaceutical Group | 11.70B |
| The United Laboratories International Holdings | 15.45B |
| Xuanzhu Biopharmaceutical | 35.02M |
| Sunshine Lake Pharma | 3.96B |
| OneRobotics (Shenzhen) | 801.23M |
Hansoh Pharmaceutical Group Company News
- 4 months ago - Innovent's License Deal Fails To Excite investors - Benzinga